Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVI
Status:
Completed
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare aspirin/acetylsalicylic acid+ clopidogrel with
aspirin/acetylsalicylic acid alone as antithrombotic treatment following TAVI for the
prevention of major ischemic events (MI, ischemic stroke) or death without increasing the
risk of major bleeding events.
Phase:
Phase 4
Details
Lead Sponsor:
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec